CoChat

A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination

Bijlsma, Merijn W., Brouwer, Matthijs C., Spanjaard, Lodewijk, van de Beek, Diederik, van der Ende, Arie · 2014 · Clinical Infectious Diseases
Cited by 86

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Vaccination with meningococcal serogroup C (MenC) conjugate (MCC) polysaccharide vaccines led to a substantial decline in MenC disease in the vaccinated and the unvaccinated population. The decline in the unvaccinated population can be explained by herd protection by reduced colonization of meningococci expressing the MenC capsule. The duration of such herd protection is unknown. METHODS: In a nationwide study from the Netherlands, we compared MenC invasive disease between 1998 and the introduction of MCC vaccination (2002) with that from 2002 to 2012, in age groups eligible and not eligible for vaccination. The proportions of isolates from clonal complexes with high serogroup C capsule expression rate during carriage (sequence type [ST] 11 and ST-8 complex) was compared between the pre- and postvaccination periods. RESULTS: A total of 814 patients with invasive MenC disease were included for analysis. There was a 99% decline in MenC disease in patients eligible for vaccination and a 93% decline in those not eligible. Thirty-six percent of the overall MenC reduction between the first and last 4 years of the observation period occurred in the unvaccinated population. Clonal complex was determined in 350 (43%) isolates. The proportion of cases caused by clonal complex ST-11 and ST-8 serogroup C meningococci decreased from 251 of 268 (94%) before, to 46 of 57 (81%) after MCC vaccine introduction (P = .004). CONCLUSIONS: Our findings provide further evidence that herd protection results from reduced carriage of virulent meningococci. Herd protection was responsible for >36% of MCC vaccine impact and lasted for ≥10 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciu601

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 26

  1. Trotter, 2007, Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines, FEMS Microbiol Rev, 31, 101, 10.1111/j.1574-6976.2006.00053.x · DOI · Paper page
  2. de Vries, 2002, Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands, Ned Tijdschr Geneeskd, 146, 1562
  3. de Greeff, 2006, Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands, Pediatr Infect Dis J, 25, 79, 10.1097/01.inf.0000195594.41449.c6 · DOI · Paper page
  4. Kaaijk, 2012, Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands, BMC Infect Dis, 12, 35, 10.1186/1471-2334-12-35 · DOI · Paper page
  5. Maiden, 2008, Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, 197, 737, 10.1086/527401 · DOI · Paper page
  6. Daugla, 2014, Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected], Lancet, 383, 40, 10.1016/S0140-6736(13)61612-8 · DOI · Paper page
  7. Campbell, 2010, Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity, Clin Vaccine Immunol, 17, 840, 10.1128/CVI.00529-09 · DOI · Paper page
  8. de Voer, 2010, Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal C conjugate vaccine, PLoS One, 5, e12144, 10.1371/journal.pone.0012144 · DOI
  9. Ishola, 2012, Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction, Clin Vaccine Immunol, 19, 1126, 10.1128/CVI.05655-11 · DOI
  10. Caugant, 2008, Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease, Infect Genet Evol, 8, 558, 10.1016/j.meegid.2008.04.002 · DOI
  11. Jolley, 2007, Molecular typing of meningococci: recommendations for target choice and nomenclature, FEMS Microbiol Rev, 31, 89, 10.1111/j.1574-6976.2006.00057.x · doi:10.1111/j.1574-6976.2006.00057.x
  12. Claus, 2005, Genetic analysis of meningococci carried by children and young adults, J Infect Dis, 191, 1263, 10.1086/428590 · DOI · Paper page
  13. Spanjaard, 1985, The incidence of bacterial meningitis in the Netherlands—a comparison of three registration systems, 1977–1982, J Infect, 11, 259, 10.1016/S0163-4453(85)93327-4 · DOI
  14. Ouchterlony, 1949, Antigen-antibody reactions in gels, Acta Pathol Microbiol Scand, 26, 507, 10.1111/j.1699-0463.1949.tb00751.x · DOI · Paper page
  15. Maiden, 1998, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc Natl Acad Sci U S A, 95, 3140, 10.1073/pnas.95.6.3140 · DOI · Paper page
  16. de Greeff, 2003, The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients, Ned Tijdschr Geneeskd, 147, 1132
  17. Fine, 2011, “Herd immunity”: a rough guide, Clin Infect Dis, 52, 911, 10.1093/cid/cir007 · DOI · Paper page
  18. Clemens, 2011, New approaches to the assessment of vaccine herd protection in clinical trials, Lancet Infect Dis, 11, 482, 10.1016/S1473-3099(10)70318-2 · DOI
  19. Miller, 2001, Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story, Vaccine, 20, S58, 10.1016/S0264-410X(01)00299-7 · DOI · Paper page
  20. Muhlemann, 1997, Can herd immunity influence the assessment of vaccine efficacy in nonrandomized studies?, Am J Public Health, 87, 113, 10.2105/AJPH.87.1.113 · DOI
  21. Hayes, 2000, Design and analysis issues in cluster-randomized trials of interventions against infectious diseases, Stat Methods Med Res, 9, 95, 10.1191/096228000670953670 · DOI
  22. Christensen, 2010, Meningococcal carriage by age: a systematic review and meta-analysis, Lancet Infect Dis, 10, 853, 10.1016/S1473-3099(10)70251-6 · DOI · Paper page
  23. Pollard, 2001, Development of natural immunity to Neisseria meningitidis, Vaccine, 19, 1327, 10.1016/S0264-410X(00)00333-9 · doi:10.1016/s0264-410x(00)00333-9
  24. Griffin, 2004, Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network, Pediatr Infect Dis J, 23, S188, 10.1097/01.inf.0000144660.53024.64 · DOI
  25. Harrison, 2010, Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era—United States, 2000–2005, J Infect Dis, 201, 1208, 10.1086/651505 · DOI
  26. Bijlsma, 2014, Epidemiology of invasive meningococcal disease from 1960 through 2012: a study of national surveillance data from the Netherlands, Lancet Infect Dis, 10.1016/S1473-3099(14)70806-0 · DOI

Cited by

See all 86

Metadata

Authors
Bijlsma, M. W., Brouwer, M. C., Spanjaard, L., van de Beek, D., & van der Ende, A.
Venue
Clinical Infectious Diseases
Published
2014-07-28
Volume
59
Issue
9
Pages
1216-1221
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2116995839
Cited by
86
References
2
FWCI
9.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination. https://app.cochat.ai/papers/10.1093/cid/ciu601
The paper
Bijlsma, M. W., Brouwer, M. C., Spanjaard, L., van de Beek, D., & van der Ende, A. (2014). A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu601

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.